Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patency Rate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02479204
What this trial is testing

Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441

Who this might be right for
Healthy Subjects
Viatris Innovation GmbH 10
Testing effectiveness (Phase 2)WithdrawnNCT01328106
What this trial is testing

Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma

Who this might be right for
GNA11 Mutation-positive Metastatic MelanomaGNAQ Mutation-positive Metastatic MelanomaCancer+1 more
GlaxoSmithKline
Not applicableLooking for participantsNCT07359638
What this trial is testing

Impact of a Mandibular Oral Repositioning Device on Sleep Quality, Heart Rate Variability, & SpO2

Who this might be right for
Sleep
University of Calgary 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03350126
What this trial is testing

IRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab

Who this might be right for
Metastatic Cancer Colorectal
GERCOR - Multidisciplinary Oncology Cooperative Group 57
Testing effectiveness (Phase 2)Study completedNCT01077726
What this trial is testing

Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression

Who this might be right for
Breast Cancer
Hoffmann-La Roche 3
Post-approval studies (Phase 4)Study completedNCT00315484
What this trial is testing

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

Who this might be right for
AnemiaChemotherapy
Ortho Biotech Products, L.P. 358
Not applicableStudy completedNCT01198444
What this trial is testing

To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives

Who this might be right for
Contraception
Bayer 11,884
Not applicableStudy completedNCT01059721
What this trial is testing

Outcome After Soft Tissue Realignment of the Tibial Insertion of the Patella Tendon

Who this might be right for
Patella Dislocation
Medical University of Graz 43
Not applicableStudy completedNCT01071148
What this trial is testing

A Phase IV, Prospective, Observational, Open Label, Single Centre Cohort Trial to be Conducted in Norway During One Year to Assess the Cumulative Pregnancy Rate in a New Series of In-vitro Fertilization (IVF) Treatment Cycles Following Three or More Previous IVF Treatment Cycles Without Live Birth

Who this might be right for
Infertility
Merck KGaA, Darmstadt, Germany 166
Testing effectiveness (Phase 2)WithdrawnNCT02140840
What this trial is testing

UARK 2014-08 A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered Trametinib

Who this might be right for
Multiple Myeloma
University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT01915589
What this trial is testing

Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 16
Post-approval studies (Phase 4)UnknownNCT00751374
What this trial is testing

Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis

Who this might be right for
Rate of Exit Site InfectionRate of Atypical Mycobacterial InfectionRate of Peritoneal Dialysis
Kwong Wah Hospital 500
Post-approval studies (Phase 4)Study completedNCT01585324
What this trial is testing

The Relationship Between Drop in Hemoglobin and Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 30
Large-scale testing (Phase 3)Study completedNCT03074045
What this trial is testing

LCS16 vs. COC User Satisfaction and Tolerability Study

Who this might be right for
Contraception
Bayer 145
Testing effectiveness (Phase 2)Study completedNCT01383707
What this trial is testing

Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 77
Testing effectiveness (Phase 2)UnknownNCT00839111
What this trial is testing

Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment

Who this might be right for
Colorectal Neoplasms
Fudan University 43
Testing effectiveness (Phase 2)UnknownNCT05582109
What this trial is testing

Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma

Who this might be right for
Objective Response Rate (ORR)
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT01830400
What this trial is testing

A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

Who this might be right for
Partial Onset Seizures
Eisai Inc. 254
Early research (Phase 1)Study completedNCT00570284
What this trial is testing

Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors

Who this might be right for
Cancer
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)UnknownNCT04156698
What this trial is testing

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

Who this might be right for
Hypopharyngeal CarcinomaImmunotherapyChemotherapy
Eye & ENT Hospital of Fudan University 51
Next Page